Generation Bio GBIO Stock
Generation Bio Price Chart
Generation Bio GBIO Financial and Trading Overview
| Generation Bio stock price | 5.34 USD |
| Previous Close | 5.34 USD |
| Open | 5.7 USD |
| Bid | 5.31 USD x 100 |
| Ask | 5.44 USD x 100 |
| Day's Range | 5.34 - 5.71 USD |
| 52 Week Range | 3 - 7.52 USD |
| Volume | 551.92K USD |
| Avg. Volume | 83.32K USD |
| Market Cap | 35.98M USD |
| Beta (5Y Monthly) | 2.006 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GBIO Valuation Measures
| Enterprise Value | -27545620 USD |
| Trailing P/E | N/A |
| Forward P/E | -3.9850748 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.3565052 |
| Price/Book (mrq) | 0.71143085 |
| Enterprise Value/Revenue | -1.804 |
| Enterprise Value/EBITDA | 0.361 |
Trading Information
Generation Bio Stock Price History
| Beta (5Y Monthly) | 2.006 |
| 52-Week Change | -23.11% |
| S&P500 52-Week Change | 32.69% |
| 52 Week High | 7.52 USD |
| 52 Week Low | 3 USD |
| 50-Day Moving Average | 5.52 USD |
| 200-Day Moving Average | 5.11 USD |
GBIO Share Statistics
| Avg. Volume (3 month) | 83.32K USD |
| Avg. Daily Volume (10-Days) | 129.07K USD |
| Shares Outstanding | 6.74M |
| Float | 4.19M |
| Short Ratio | 0.03 |
| % Held by Insiders | 14.29% |
| % Held by Institutions | 66.07% |
| Shares Short | 2.07K |
| Short % of Float | 0.040% |
| Short % of Shares Outstanding | 0.029% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2019.95% |
| Gross Margin | -212.16% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.39% |
| Return on Equity (ttm) | -80.80% |
Income Statement
| Revenue (ttm) | 15.27M USD |
| Revenue Per Share (ttm) | 2.28 USD |
| Quarterly Revenue Growth (yoy) | -78.90% |
| Gross Profit (ttm) | -32398000 USD |
| EBITDA | -76380000 USD |
| Net Income Avi to Common (ttm) | -62627000 USD |
| Diluted EPS (ttm) | -9.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 89.62M USD |
| Total Cash Per Share (mrq) | 13.3 USD |
| Total Debt (mrq) | 26.1M USD |
| Total Debt/Equity (mrq) | 51.61 USD |
| Current Ratio (mrq) | 4.442 |
| Book Value Per Share (mrq) | 7.506 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -113652000 USD |
| Levered Free Cash Flow (ttm) | -40196752 USD |
Profile of Generation Bio
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 301 Binney Street |
| ZIP | 02142 |
| Phone | 617 655 7500 |
| Website | https://generationbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Q&A For Generation Bio Stock
What is a current GBIO stock price?
Generation Bio GBIO stock price today per share is 5.34 USD.
How to purchase Generation Bio stock?
You can buy GBIO shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Generation Bio?
The stock symbol or ticker of Generation Bio is GBIO.
Which industry does the Generation Bio company belong to?
The Generation Bio industry is Biotechnology.
How many shares does Generation Bio have in circulation?
The max supply of Generation Bio shares is 6.74M.
What is Generation Bio Price to Earnings Ratio (PE Ratio)?
Generation Bio PE Ratio is 0.00000000 now.
What was Generation Bio earnings per share over the trailing 12 months (TTM)?
Generation Bio EPS is 0 USD over the trailing 12 months.
Which sector does the Generation Bio company belong to?
The Generation Bio sector is Healthcare.
Generation Bio GBIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26695.02 USD — |
-0.59
|
2.96B USD — | 26554.24 USD — | 26707.69 USD — | — - | 2.96B USD — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 13094.57 USD — |
-0.66
|
— — | 13032.51 USD — | 13104.32 USD — | — - | — — |
| US Tech Biotechnology NBI | 5951.7 USD — |
+2.49
|
— — | 5868.75 USD — | 5967.75 USD — | — - | — — |
| US Tech Health Care IXHC | 1162.89 USD — |
+2.59
|
— — | 1146.48 USD — | 1165.81 USD — | — - | — — |
- {{ link.label }} {{link}}